Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2025 earnings results today.
Revenues increased 3% year-over-year to $12.2 billion.
GAAP net income attributable to Bristol Myers Squibb was $2.2 billion, or $1.08 per share, compared to $1.2 billion, or $0.60 per share, last year. Adjusted EPS was $1.63, down 9% YoY.
For full-year 2025, revenue is expected to be $47.5-48.0 billion. Adjusted EPS is expected to be $6.40-6.60.
The post Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers first appeared on AlphaStreet.
—
Blog powered by G6
Disclaimer! A guest author has made this post. G6 has not checked the post. its content and attachments and under no circumstances will G6 be held responsible or liable in any way for any claims, damages, losses, expenses, costs or liabilities whatsoever (including, without limitation, any direct or indirect damages for loss of profits, business interruption or loss of information) resulting or arising directly or indirectly from your use of or inability to use this website or any websites linked to it, or from your reliance on the information and material on this website, even if the G6 has been advised of the possibility of such damages in advance.
For any inquiries, please contact [email protected]
